Search Result

Results for "

ADAM

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Acetyl-CoA Carboxylase (1) ADAMTS (1) ADC Antibody (1) Adenosine Receptor (2) Akt (3) AMPK (1) Amyloid-β (1) Angiotensin-converting Enzyme (ACE) (1) Apoptosis (9) Bacterial (1) Bcl-2 Family (2) c-Myc (1) Caspase (2) CCR (1) Cholecystokinin Receptor (1) Cyclin G-associated Kinase (GAK) (1) DNA/RNA Synthesis (1) Drug-Linker Conjugates for ADC (1) EGFR (2) ERK (2) FAK (1) Fluorescent Dye (4) FOXO (1) HDAC (1) HIV (1) IFNAR (1) Interleukin Related (3) Isotope-Labeled Compounds (1) JNK (1) LAG-3 (1) mAChR (1) Microtubule/Tubulin (1) MMP (40) NF-κB (4) Notch (1) Nucleoside Antimetabolite/Analog (2) P2X Receptor (1) p38 MAPK (3) Phosphatase (1) Reference Standards (4) SARS-CoV (6) SDCBP (1) Small Interfering RNA (siRNA) (48) Syk (1) TNF Receptor (7) TREM receptor (1)
By Research Areas:	Cancer (31) Cardiovascular Disease (3) Endocrinology (1) Infection (8) Inflammation/Immunology (11) Metabolic Disease (2) Neurological Disease (8)
Oligonucleotides:	Rat Pre-designed siRNA Sets (14) Mouse Pre-designed siRNA Sets (15) Human Pre-designed siRNA Sets (19) siRNAs (48)

Inhibitors & Agonists

Fluorescent Dyes

Biochemical Assay Reagents

Peptides

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

GMP Molecules

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-16657

TAPI-1 10+ Cited Publications	MMP NF-κB Apoptosis TNF Receptor	Inflammation/Immunology Cancer
TAPI-1 is a broad-spectrum MMP inhibitor and NF-κB p65 inhibitor that targets **ADAM17/TACE, ADAM10 and other proteins. TAPI-1 reduces the proteolytic cleavage of membrane-bound TNF-α, decreases TNF-α levels, inhibits NF-κB pathway activation, and downregulates profibrotic markers. TAPI-1 reduces the proportion of proinflammatory immune cells, alleviates cardiac and airway fibrosis, and improves cardiac function after myocardial infarction. Meanwhile, TAPI-1 inhibits the viability, migration and invasion of esophageal squamous cell carcinoma cells, enhances the chemosensitivity of Cisplatin (HY-17394), induces apoptosis**, and shows low toxicity to normal esophageal epithelial cells. TAPI-1 can be widely used in studies related to myocardial infarction-induced heart failure, severe traumatic tracheal stenosis, esophageal squamous cell carcinoma and other conditions .

HY-115670

GW280264X 5+ Cited Publications	MMP	Inflammation/Immunology Cancer
GW280264X is the mixed ADAM10/TACE (ADAM17) metalloproteinases inhibitor. GW280264X potently blocks TACE (ADAM17) and *ADAM10* with IC₅₀s of 8.0 nM and 11.5 nM, respectively . ADAM10 and 17 modulate the immunogenicity of glioblastoma-initiating cells .

HY-19956

GI254023X Maximum Cited Publications 19 Publications Verification GI4023; SRI028594	MMP	Cancer
GI254023X is a potent MMP9 and *ADAM10* inhibitor with IC₅₀s of 2.5 and 5.3 nM, respectively.

HY-110397

KP-457 3 Publications Verification	MMP	Cardiovascular Disease
KP-457 is a selective a disintegrin and metalloproteinase 17 (ADAM17) inhibitor, with higher selectivity for ADAM17 than for other MMPs and ADAM10, and IC₅₀s are 11.1 nM (ADAM17), 748 nM (ADAM10), 717 nM (MMP2), 9760 nM (MMP3), 2200 nM (MMP8), 5410 nM (MMP9), 930 nM (MMP13), 2140 nM (MMP14), and 7100 nM (MMP17), respectively.

HY-100211

TAPI-2 5 Publications Verification TNF Protease Inhibitor 2	MMP SARS-CoV	Cancer
TAPI-2 (TNF Protease Inhibitor 2) is a broad-spectrum inhibitor of matrix metalloprotease (MMP), tumour necrosis factorα-converting enzyme (TACE) and a disintegrin and metalloproteinase (ADAM), with an IC₅₀ of 20 μM for MMP . TAPI-2 blocks the entry of infectious SARS-CoV .

HY-10293

Aderbasib 1 Publications Verification INCB007839; INCB7839	MMP	Cancer
Aderbasib (INCB007839) is a potent, orally active and target specific low nanomolar hydroxamate-based inhibitor of *ADAM10* and *ADAM17*. Aderbasib exhibits robust antineoplastic activity and can be used for cancer research, including diffuse large B-cell non-Hodgkin lymphoma, HER2 ⁺ breast cancer, gliomas, et al .

HY-101984

N6,N6-Dimethyladenosine 4 Publications Verification	Nucleoside Antimetabolite/Analog Adenosine Receptor Akt SARS-CoV	Infection Cancer
N6,N6-Dimethyladenosine, a modified ribonucleoside, is an endogenous A3 adenosine receptor ligand. N6,N6-Dimethyladenosine is an AKT inhibitor with antitumor effects. N6, N6-Dimethyladenosine targets SARS-CoV-2 entry protein *ADAM17*. N6, N6-Dimethyladenosine robustly inhibits AKT signaling in a variety of non-small cell lung cancer cell lines .

HY-101448

TMI-1 1 Publications Verification WAY-171318	MMP Apoptosis Interleukin Related TNF Receptor Caspase	Infection Neurological Disease Inflammation/Immunology Cancer
TMI-1 (WAY-171318) inhibits TNF converting enzyme (TACE) (IC₅₀ of 8.4 nM), *ADAM-TS-4, ADAM-17* and various MMPs with oral activity. TMI-1 significantly suppresses the secretion of TNF-α , alleviating collagen-induced arthritis in mice. TMI-1 inhibits cancer cell proliferation, induces apoptosis through a caspase-dependent pathway. TMI-1 also reverses TRPV1 upregulation and lowers the levels of inflammatory factors (TNF-α、IL-1β、IL-6) in nerve cells, protecting against paclitaxel-induced neurotoxicity. TMI-1 leads to changes in pro-atherogenic lipoprotein profiles, but does not affect the progression of early lesions .

HY-16657A

(S,S)-TAPI-1	MMP mAChR	Neurological Disease Inflammation/Immunology Cancer
(S,S)-TAPI-1 is an isomer of TAPI-1. TAPI-1 is a TACE (ADAM17) inhibitor and blocks the shedding of several cell surface proteins. TAPI-1 is also a metalloproteinase (MMP) inhibitor .

HY-N0863

Methyl protodioscin NSC-698790; Smilax saponin B	Bcl-2 Family Apoptosis Akt c-Myc ERK p38 MAPK JNK FOXO	Cancer
Methyl protodioscin (NSC-698790; Smilax saponin B) is a multi-target, selective, steroidal diglycoside inhibitor with antitumor activity that induces cell cycle arrest. The mechanism of action of Methyl protodioscin is complex, involving the induction of G2/M cell cycle arrest, regulation of the Bcl-2/Bax apoptotic pathway, inhibition of the Akt1/c-Myc axis and MAPK/ERK signaling, while simultaneously downregulating *ADAM15* and inducing FOXO1 to reduce cholesterol synthesis. It also inhibits the JNK/c-Jun pathway, reducing the production of inflammatory factors (IL-6, TNF-α). Methyl protodioscin exhibits significant antitumor (inhibiting proliferation, migration, invasion, and inducing apoptosis), anti-inflammatory, and anti-restenosis activities. Methyl protodioscin can be used in research on lung cancer, prostate cancer, pancreatic cancer, and other tumors, as well as inflammatory diseases such as airway inflammation and enteritis .

HY-120852

JG26 1 Publications Verification	Angiotensin-converting Enzyme (ACE) MMP EGFR ERK SARS-CoV	Infection Cardiovascular Disease Cancer
JG26 is an *ADAM* inhibitor with IC₅₀ values of 12 nM, 1.9 nM, and 150 nM for ADAM8, ADAM17, and ADAM10, respectively. JG26 inhibits MMP-12 with an IC₅₀ value of 9.4 nM. JG26 inhibits AngII (HY-13948)-induced EGFR transactivation and ERK activation. JG26 increases the expression of ACE2, inhibits the cleavage of CD23, reduces the infection of SARS-CoV-2. JG26 inhibits colorectal cancer metastasis. JG26 can be used for research on Hodgkin lymphoma and vascular diseases .

HY-123931

ZLDI-8 1 Publications Verification	Notch Phosphatase Apoptosis	Cancer
ZLDI-8 is a Notch activating/cleaving enzyme *ADAM-17* inhibitor and inhibits the cleavage of Notch protein. ZLDI-8 decreases the expression of pro-survival/anti-apoptosis and epithelial-mesenchymal transition (EMT) related proteins. ZLDI-8 is also a competitive and irreversible tyrosine phosphatase (Lyp) inhibitor with an IC₅₀ of 31.6 μM and a K_i of 26.22 μM. ZLDI-8 inhibits the growth of MHCC97-H cells with an IC₅₀ of 5.32 μM .

HY-139441

DM21	Drug-Linker Conjugates for ADC Microtubule/Tubulin	Cancer
DM21 is a next-generation linker-payload that combines a maytansinoid microtubule-disrupting payload with a stable tripeptide linker. DM21 is conjugated with a humanized antibody against ADAM9 to obtain IMGC936 .

HY-20070

BMS-566394	TNF Receptor	Inflammation/Immunology
BMS-566394 is a selective, orally active TACE (ADAM17) inhibitor. BMS-566394 inhibits LPS-induced TNF-α production in whole blood. BMS-566394 selectively inhibits TACE activity .

HY-19667A

BMS-561392 formate 2 Publications Verification DPC 333 formate	TNF Receptor NF-κB Apoptosis p38 MAPK	Neurological Disease Inflammation/Immunology
BMS-561392 formate (DPC 333 formate) is a selective *ADAM17(TACE*) inhibitor. BMS-561392 formate inhibits TNF-α secretion by regulating signaling pathways such as p44 MAPK and NF-κB. BMS-561392 formate also affects the survival of central nervous system-related cells including oligodendrocytes and microglia. BMS-561392 formate promotes microglial apoptosis, enlarges the injury area and exacerbates astrogliosis in a mouse spinal cord injury model. BMS-561392 formate can be used in research related to spinal cord injury and inflammatory diseases .

HY-17377

Vicriviroc maleate SCH-417690 maleate; SCH-D maleate	CCR HIV	Infection Endocrinology Cancer
Vicriviroc maleate (SCH-417690 maleate; SCH-D maleate) is a potent, selective, oral bioavailable and CNS penetrated antagonist of CCR5, with a K_i of 2.5 nM, and also inhibits HIV-1 in PBMC cells, with IC₉₀s of 3.3 nM (JrFL), 2.8 nM (ADA-M), 1.8 nM (301657), 4.9 nM (JV1083) and 10 nM (RU 570).

HY-12636

INCB3619	MMP Apoptosis	Cancer
INCB3619 is a selective and orally active *ADAM* inhibitor with IC₅₀ of 22 nM and 14 nM for ADAM10 and ADAM17, respectively. INCB3619 has anti-tumor activity .

HY-P3722

Mca-PLAQAV-Dpa-RSSSR-NH2 1 Publications Verification	Fluorescent Dye MMP	Others
Mca-PLAQAV-Dpa-RSSSR-NH2 is a fluorescent substrate peptide that can be used to detect *ADAM9, ADAM10, and tumor necrosis factor-α converting enzyme (TACE/ADAM17).* Mca-PLAQAV-Dpa-RSSSR-NH2 is a fluorescence resonance energy transfer-based substrate, and its activity can be determined by changes in fluorescence intensity upon cleavage (Ex = 320 nm ; Em = 405 nm) .

HY-P1676

cyclo(RLsKDK) 2 Publications Verification BK-1361	MMP	Cancer
cyclo(RLsKDK) (BK-1361) is a specific inhibitor of metalloproteinase *ADAM8* with an IC₅₀ value of 182 nM. cyclo(RLsKDK) has potential applications in inflammatory diseases and cancer .

HY-118694

TAPI-0	TNF Receptor MMP Bacterial	Infection Cancer
TAPI-0 is a TACE (TNF-α converting enzyme; ADAM17) inhibitor with an IC₅₀ of 100 nM. TAPI-0 is a MMP inhibitor and also attenuates TNF-α processing .

HY-P990027

Izeltabart IMGC-936 antibody; MGA021	ADC Antibody MMP	Cancer
Izeltabart (MGA021) is a humanized IgG1 monoclonal antibody targeting *ADAM9, which can be used as an ADC Antibody* to synthesize the ADC molecule IMGC936 (Izeltabart Tapatansine). Izeltabart can be used in the study of cancer .

HY-108675

PPNDS tetrasodium	MMP P2X Receptor	Infection Cancer
PPNDS tetrasodium is a selective and competitive meprin β inhibitor (IC₅₀: 80 nM, K_i: 8 nM), and also inhibits *ADAM10* (IC₅₀: 1.2 μM). PPNDS tetrasodium is also a P2X1 receptor antagonist. PPNDS is an agonist for the ATP receptor of Paramecium. PPNDS tetrasodium potently inhibits polymerases from viruses. PPNDS tetrasodium can be used in the research of infection and cancers .

HY-124813

PDZ1i 113B7	FAK EGFR MMP NF-κB SDCBP	Cancer
PDZ1i (113B7) is a inhibitor of MDA-9/Syntenin, with selective binding to the PDZ1 domain. PDZ1i inhibits radiation-induced invasion of glioblastoma (GBM) cells, radiosensitizes GBM cells, and impairs GBM-related signaling pathways (including Src/EphA2, EGFRvIII/FAK, and NF-κB). PDZ1i reduces radiation-induced secretion of invasion-related proteases (MMP-2, MMP-9, *ADAM9*). PDZ1i shows anti-tumor effects in nude mice bearing intracranial U1242-luc xenografts or GBM xenografts. PDZ1i can be used for the study of glioblastoma (GBM), breast cancer and prostate cancer .

HY-P3722A

Mca-PLAQAV-Dpa-RSSSR-NH2 TFA 1 Publications Verification	Fluorescent Dye MMP	Others
Mca-PLAQAV-Dpa-RSSSR-NH2 TFA is a fluorescent substrate peptide that can be used to detect *ADAM9, ADAM10, and tumor necrosis factor-α converting enzyme (TACE/ADAM17).* Mca-PLAQAV-Dpa-RSSSR-NH2 TFA is a fluorescence resonance energy transfer-based substrate, and its activity can be determined by changes in fluorescence intensity upon cleavage (Ex = 320 nm ; Em = 405 nm) .

HY-19667

BMS-561392 DPC 333	TNF Receptor NF-κB Apoptosis p38 MAPK	Neurological Disease Inflammation/Immunology
BMS-561392 (BMS-561392) is a selective *ADAM17(TACE*) inhibitor. BMS-561392 inhibits TNF-α secretion by regulating signaling pathways such as p44 MAPK and NF-κB. BMS-561392 also affects the survival of central nervous system-related cells including oligodendrocytes and microglia. BMS-561392 promotes microglial apoptosis, enlarges the injury area and exacerbates astrogliosis in a mouse spinal cord injury model. BMS-561392 can be used in research related to spinal cord injury and inflammatory diseases .

HY-P10174A

ADAM-17 Substrate TFA	Fluorescent Dye MMP	Others
ADAM-17 Substrate is a fluorescent substrate of ADAM .

HY-175876

ADAM17-IN-1	MMP Interleukin Related	Inflammation/Immunology
ADAM17-IN-1 is a selective inhibitor of *ADAM17. ADAM17-IN-1 inhibits ADAM17* activity to reduce metabolic activity of dendritic cells (DCs), impair DC antigen-presenting function, suppress allergen-specific Th2 cell polarization, and reduce Th2 cytokine (IL-4, IL-5, IL-13) secretion. ADAM17-IN-1 demonstrates protective efficacy against house dust mite (HDM)-induced type 2/eosinophilic airway inflammation in mice. ADAM17-IN-1 can be used for the study of type 2-high allergic asthma .

HY-172394

ZSNI-21	HDAC ADAMTS Apoptosis Bcl-2 Family Cyclin G-associated Kinase (GAK)	Cancer
ZSNI-21 is a *ADAM17/HDAC2* inhibitor with *ADAM17* IC₅₀ 0.939 μM and HDAC2 IC₅₀ 0.844 μM. ZSNI-21 regulates the expression of apoptosis-related proteins (Bax, Bcl-2) and Cyclin D1, and induces apoptosis.. ZSNI-21 can be used for the research of hepatocellular carcinoma, breast cancer, and non-small cell lung cancer .

HY-P1676A

cyclo(RLsKDK) TFA 2 Publications Verification BK-1361 TFA	MMP	Cancer
cyclo(RLsKDK) (TFA) (BK-1361 (TFA)) is a specific inhibitor of metalloproteinase *ADAM8* with an IC₅₀ value of 182 nM. cyclo(RLsKDK) (TFA) has potential applications in inflammatory diseases and cancer .

HY-P99027

Ieramilimab LAG525; IMP701; Hu5A8	LAG-3	Cancer
Ieramilimab (LAG525; IMP701) is a humanized IgG4 monoclonal antibody that binds to LAG-3, resulting in inhibition of LAG-3 interaction with MHC-II molecules. Ieramilimab restores T-cell and NK-cell-mediated antileukemic immunity by reducing exhaustion and augmenting cytokine output and cytotoxicity. Ieramilimab increases the infiltration of cytotoxic T lymphocytes and reduces baseline densities of regulatory T cells (Tregs) and ADAM10-expressing tumor cells. Ieramilimab can be used for the study of various malignancies including melanoma, RCC, and advanced solid tumors .

HY-101984R

N6,N6-Dimethyladenosine (Standard)	Reference Standards Nucleoside Antimetabolite/Analog Adenosine Receptor Akt SARS-CoV	Infection Cancer
N6,N6-Dimethyladenosine (Standard) is the analytical standard of N6,N6-Dimethyladenosine (HY-101984). This product is intended for research and analytical applications. N6,N6-Dimethyladenosine, a modified ribonucleoside, is an endogenous A3 adenosine receptor ligand. N6,N6-Dimethyladenosine is an AKT inhibitor with antitumor effects. N6, N6-Dimethyladenosine targets SARS-CoV-2 entry protein *ADAM17*. N6, N6-Dimethyladenosine robustly inhibits AKT signaling in a variety of non-small cell lung cancer cell lines.

HY-132917

ADAM8-IN-1	MMP	Cancer
ADAM8-IN-1 is a potent *ADAM8* inhibitor with an IC₅₀ value of 73 nM.

HY-RS00266

Adam10 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA) MMP	Others
Adam10 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Adam10 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Adam10 Mouse Pre-designed siRNA Set A Adam10 Mouse Pre-designed siRNA Set A

HY-RS00265

ADAM10 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA) MMP	Others
ADAM10 Human Pre-designed siRNA Set A contains three designed siRNAs for ADAM10 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ADAM10 Human Pre-designed siRNA Set A ADAM10 Human Pre-designed siRNA Set A

HY-RS00271

ADAM17 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA) MMP	Others
ADAM17 Human Pre-designed siRNA Set A contains three designed siRNAs for ADAM17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ADAM17 Human Pre-designed siRNA Set A ADAM17 Human Pre-designed siRNA Set A

HY-P11540

CCKBR agonist-1	Cholecystokinin Receptor MMP Amyloid-β	Neurological Disease
CCKBR agonist-1 (Compound 3r1) is a Gq-protein-preferring cholecystokinin B receptor (CCKBR) agonist with an EC₅₀ of 35 pM. CCKBR agonist-1 significantly increases the survival rate of neurons, with an EC₅₀ of 37 pM. CCKBR agonist-1 can improve the cognitive decline in mice by upregulating α-secretase (ADAM10) and calcium signaling molecule PLCB4, reduce the number of amyloid β (Aβ) plaques, and promote long-term potentiation (LTP). CCKBR agonist-1 can be used for the study of Alzheimer's disease .

HY-110397G

KP-457	MMP	Cardiovascular Disease
KP-457 (GMP) is KP-457 (HY-110397) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture.KP-457 is a selective a disintegrin and metalloproteinase 17 (ADAM17) inhibitor, with higher selectivity for ADAM17 than for other MMPs and ADAM10, and IC₅₀s are 11.1 nM (ADAM17), 748 nM (ADAM10), 717 nM (MMP2), 9760 nM (MMP3), 2200 nM (MMP8), 5410 nM (MMP9), 930 nM (MMP13), 2140 nM (MMP14), and 7100 nM (MMP17), respectively .

HY-P10174

ADAM-17 Substrate	Fluorescent Dye MMP	Others
ADAM-17 Substrate is a fluorescent substrate of ADAM .

HY-156407

Adam-20-S	Others	Others
Adam-20-S is a potent glucosinolate sulfatase inhibitor with an IC₅₀ value of 9.04 μg/mL. Adam-20-S impaires glucosinolate metabolism to produce more toxic isothiocyanates in P. xylostella .

HY-RS00283

ADAM32 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ADAM32 Human Pre-designed siRNA Set A contains three designed siRNAs for ADAM32 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ADAM32 Human Pre-designed siRNA Set A ADAM32 Human Pre-designed siRNA Set A

HY-RS19049

Adam32 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Adam32 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Adam32 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Adam32 Mouse Pre-designed siRNA Set A Adam32 Mouse Pre-designed siRNA Set A

HY-RS22377

Adam2 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Adam2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Adam2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Adam2 Mouse Pre-designed siRNA Set A Adam2 Mouse Pre-designed siRNA Set A

HY-RS00273

Adam17 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA) MMP	Others
Adam17 Rat Pre-designed siRNA Set A contains three designed siRNAs for Adam17 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Adam17 Rat Pre-designed siRNA Set A Adam17 Rat Pre-designed siRNA Set A

HY-RS00280

ADAM28 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ADAM28 Human Pre-designed siRNA Set A contains three designed siRNAs for ADAM28 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ADAM28 Human Pre-designed siRNA Set A ADAM28 Human Pre-designed siRNA Set A

HY-RS19048

Adam11 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Adam11 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Adam11 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Adam11 Mouse Pre-designed siRNA Set A Adam11 Mouse Pre-designed siRNA Set A

HY-RS24558

Adam12 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Adam12 Rat Pre-designed siRNA Set A contains three designed siRNAs for Adam12 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Adam12 Rat Pre-designed siRNA Set A Adam12 Rat Pre-designed siRNA Set A

HY-RS18194

Adam19 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Adam19 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Adam19 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Adam19 Mouse Pre-designed siRNA Set A Adam19 Mouse Pre-designed siRNA Set A

HY-RS00281

ADAM29 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ADAM29 Human Pre-designed siRNA Set A contains three designed siRNAs for ADAM29 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ADAM29 Human Pre-designed siRNA Set A ADAM29 Human Pre-designed siRNA Set A

HY-RS00277

ADAM21 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
ADAM21 Human Pre-designed siRNA Set A contains three designed siRNAs for ADAM21 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

ADAM21 Human Pre-designed siRNA Set A ADAM21 Human Pre-designed siRNA Set A

HY-RS24668

Adam19 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Adam19 Rat Pre-designed siRNA Set A contains three designed siRNAs for Adam19 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Adam19 Rat Pre-designed siRNA Set A Adam19 Rat Pre-designed siRNA Set A

Cat. No.	Product Name	Category	Target	Chemical Structure